Biogen Inc.
Explore Biogen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Biogen Inc.
Explore Biogen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2024 Revenue
$9.6B
▼ 1.1% vs FY2023 ($9.7B)
Net Income: $1.2B
Source: Annual report / company filing
Biogen Inc. reported $9.6B in revenue for fiscal year 2024. This represents a decline of 1.1% compared to the 2023 figure of $9.7B. In 2025, revenue increased to $9.9B.
The decline moderated to 1.1% in 2024 with revenue of $9.62 billion, as ramping Leqembi and Skyclarys sales nearly offset ongoing erosion in the legacy multiple sclerosis portfolio.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $9.9B | — | +2.8% |
| FY2024 | $9.6B | $1.2B | -1.1% |
| FY2023 | $9.7B | — | -4.3% |
| FY2022 | $10.2B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.